drugset / Trial / NCT02975219

Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis

NCT02975219 ↗

Phase 1 Unknown 10 enrolled University Medical Center Groningen
NaSingle-groupOpen-labelTreatment

Summary

Incomplete resection of endometriosis lesions often results in recurrence of symptoms and the need for repeated surgery, with considerable associated morbidity. The aim of this pilot project is to determine the feasibility of fluorescence imaging to improve the treatment of endometriosis in the future.

Timeline

Start
2017-05-01
Primary completion
2019-01
Completion
2019-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab-800CW Diagnostic / imaging agent 4.5 mg Intravenous

Indications